Archive: 24/03/2015

Gilead's Harvoni accepted in Canadian health plan

Gilead Sciences said multiple Canadian provinces will provide access to the biotechnology company's hepatitis C drug Harvoni following a positive reimbursement recommendation from regulators.

page 7 from 10